KURT VON EMSTER Insider Trading $CRSP CRISPR Therapeutics AG

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for KURT VON EMSTER.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of KURT VON EMSTER. KURT VON EMSTER is Director in CymaBay Therapeutics, Inc. ($CBAY) and Director in Vaxcyte, Inc. ($PCVX) and Director in CRISPR Therapeutics AG ($CRSP) and Director in Vera Therapeutics, Inc. ($VERA).

KURT VON EMSTER in CRISPR Therapeutics AG

Trading Symbol: CRSP
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of KURT VON EMSTER: Director
Holdings: 1,234,193 shares
Current Value: $19,438,540
Latest Transaction: Dec 19 2018
$CRSP Market Capitalization: $605.88M
$CRSP Previous Close: $15.75

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of KURT VON EMSTER in CRISPR Therapeutics AG

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, CRSP, CBAY, PCVX, VERA

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Dec 19 2018CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorSellS29.7069,9252,077,1011,164,2681.2 M to 1.2 M (-5.67 %)
Dec 19 2018CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorSellS33.173,00999,7971,234,1931.2 M to 1.2 M (-0.24 %)
Jun 18 2018CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorOption ExerciseA59.3115,000889,65015,000
Jun 07 2018CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorOption ExerciseX5.752,00011,5000
Jun 07 2018CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorSellS12.5192011,50918,31619.2 K to 18.3 K (-4.78 %)
Jun 07 2018CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorSellX5.752,00011,50019,23621.2 K to 19.2 K (-9.42 %)
May 15 2018CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorSellS52.208,900464,5401,237,2021.2 M to 1.2 M (-0.71 %)
May 15 2018CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorSellS52.9320,8811,105,3131,246,1021.3 M to 1.2 M (-1.65 %)
May 15 2018CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorSellS53.8653,9272,904,5781,266,9831.3 M to 1.3 M (-4.08 %)
May 15 2018CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorSellS54.99126,9016,978,2731,320,9101.4 M to 1.3 M (-8.77 %)
May 15 2018CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorSellS55.7273,1444,075,7231,447,8111.5 M to 1.4 M (-4.81 %)
May 15 2018CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorSellS56.90116,2476,614,1291,520,9551.6 M to 1.5 M (-7.10 %)
May 15 2018CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorSellS51.738,633446,5541,637,2021.6 M to 1.6 M (-0.52 %)
May 15 2018CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorSellS52.46127,8906,708,6111,645,8351.8 M to 1.6 M (-7.21 %)
May 15 2018CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorSellS53.36113,4776,054,7361,773,7251.9 M to 1.8 M (-6.01 %)
Jan 11 2018CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorBuyP22.7565,9341,499,9991,887,2021.8 M to 1.9 M (+3.62 %)
Jan 09 2018CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorSellS26.9692,3372,489,4061,821,2681.9 M to 1.8 M (-4.83 %)
Jan 04 2018CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorSellS26.7637,7541,010,1231,913,6052 M to 1.9 M (-1.93 %)
Aug 30 2017CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorSellS19.7988,0111,741,7381,951,3592 M to 2 M (-4.32 %)
Aug 28 2017CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorSellS19.5214,913291,1022,039,3702.1 M to 2 M (-0.73 %)
Aug 28 2017CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorSellS19.237,868151,3022,054,2832.1 M to 2.1 M (-0.38 %)
Aug 24 2017CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorSellS18.537,035130,3592,062,1512.1 M to 2.1 M (-0.34 %)
Aug 24 2017CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorSellS18.5310,954202,9782,069,1862.1 M to 2.1 M (-0.53 %)
Aug 22 2017CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorSellS18.511,25023,1382,080,1402.1 M to 2.1 M (-0.06 %)
Aug 22 2017CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorSellS18.531,90035,2072,081,3902.1 M to 2.1 M (-0.09 %)
Aug 18 2017CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorSellS18.7413,593254,7332,083,2902.1 M to 2.1 M (-0.65 %)
Aug 18 2017CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorSellS19.2720,548395,9602,096,8832.1 M to 2.1 M (-0.97 %)
Aug 16 2017CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorSellS19.5325,586499,6952,117,4312.1 M to 2.1 M (-1.19 %)
Aug 16 2017CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorSellS19.6429,983588,8662,143,0172.2 M to 2.1 M (-1.38 %)
Aug 09 2017CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorSellS18.7119,850371,3942,190,8722.2 M to 2.2 M (-0.90 %)
Aug 09 2017CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorSellS18.5315,623289,4942,210,7222.2 M to 2.2 M (-0.70 %)
Aug 07 2017CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorSellS18.503,06856,7582,226,3452.2 M to 2.2 M (-0.14 %)
Aug 07 2017CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorSellS17.7747,409842,4582,229,4132.3 M to 2.2 M (-2.08 %)
Aug 02 2017CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorSellS17.502644,6202,276,8222.3 M to 2.3 M (-0.01 %)
Aug 02 2017CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorSellS17.515,24891,8712,277,0862.3 M to 2.3 M (-0.23 %)
Jul 31 2017CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorSellS17.654007,0602,282,3342.3 M to 2.3 M (-0.02 %)
Jul 31 2017CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorSellS17.6340,912721,0742,282,7342.3 M to 2.3 M (-1.76 %)
Jul 27 2017CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorSellS17.6323,744418,6072,323,6462.3 M to 2.3 M (-1.01 %)
Jul 27 2017CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorSellS17.529,186160,9392,347,3902.4 M to 2.3 M (-0.39 %)
Jul 17 2017CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorSellS16.8236,230609,3892,356,5762.4 M to 2.4 M (-1.51 %)
Jul 17 2017CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorSellS16.8733,629567,3212,392,8062.4 M to 2.4 M (-1.39 %)
Jul 13 2017CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorSellS16.6017,872296,6752,408,5632.4 M to 2.4 M (-0.74 %)
Jul 13 2017CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorSellS16.5214,120233,2622,426,4352.4 M to 2.4 M (-0.58 %)
Jul 07 2017CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorSellS16.264,25469,1702,440,5552.4 M to 2.4 M (-0.17 %)
Jun 30 2017CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorSellS16.5211,610191,7972,444,8092.5 M to 2.4 M (-0.47 %)
Jun 30 2017CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorSellS17.0431,592538,3282,456,4192.5 M to 2.5 M (-1.27 %)
Jun 28 2017CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorSellS17.4333,434582,7552,488,0112.5 M to 2.5 M (-1.33 %)
Jun 28 2017CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorSellS16.8348,001807,8572,521,4452.6 M to 2.5 M (-1.87 %)
Jun 26 2017CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorSellS16.2330,841500,5492,569,4462.6 M to 2.6 M (-1.19 %)
Jun 26 2017CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorSellS16.211,52724,7532,600,2872.6 M to 2.6 M (-0.06 %)
Jun 02 2017CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorOption ExerciseA13.6215,000204,30015,000
Feb 10 2017CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorOption ExerciseC0.00191,76400
Feb 10 2017CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorOption ExerciseC0.002,354,05000
Feb 10 2017CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorBuyP14.0056,000784,0002,601,8142.5 M to 2.6 M (+2.20 %)
Feb 10 2017CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorBuyC0.00191,76402,545,8142.4 M to 2.5 M (+8.15 %)
Feb 10 2017CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorBuyC0.002,354,05002,354,0500 to 2.4 M
Oct 20 2016CRSPCRISPR Therapeutic ...EMSTER KURT VONDirectorOption ExerciseA14.0030,000420,00030,000

Page:   1